Human β-defensin 2 expression in ELBW infants with severe necrotizing enterocolitis

Pediatric Research

Volumn 72, Issue 5, 2012, Pages 513-520

  Jenke, Andreas C W ^a   Zilbauer, Matthias ^b   Postberg, Jan ^a   Wirth, Stefan ^a  

^a UNIVERSITY OF WITTEN HERDECKE   (Germany)

^b ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA DEFENSIN; BETA DEFENSIN 2; CYTOKINE; INTERLEUKIN 8; MESSENGER RNA; POLYPEPTIDE ANTIBIOTIC AGENT; TOLL LIKE RECEPTOR 4; VILLIN;

ABDOMINAL SURGERY; ARTICLE; BACTERIUM; CHORIOAMNIONITIS; CONCENTRATION (PARAMETERS); DISEASE COURSE; DISEASE PREDISPOSITION; DISEASE SEVERITY; EXTREMELY LOW BIRTH WEIGHT; FECES ANALYSIS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; INFANCY; INFANT; INNATE IMMUNITY; INTESTINE SURGERY; MAJOR CLINICAL STUDY; MALE; MECONIUM; NECROTIZING COLITIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN EXPRESSION; STOMACH BIOPSY;

ANALYSIS OF VARIANCE; BETA-DEFENSINS; BIOLOGICAL MARKERS; BIOPSY; ENTEROCOLITIS, NECROTIZING; FECES; FEMALE; GENE EXPRESSION REGULATION; GERMANY; GESTATIONAL AGE; HUMANS; IMMUNITY, MUCOSAL; INFANT, EXTREMELY LOW BIRTH WEIGHT; INFANT, NEWBORN; INTERLEUKIN-8; INTESTINAL MUCOSA; LYMPHOCYTE ANTIGEN 96; MALE; MECONIUM; MICROFILAMENT PROTEINS; PREVALENCE; PROGNOSIS; PROSPECTIVE STUDIES; RNA, MESSENGER; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TOLL-LIKE RECEPTOR 4;

EID: 84870563700     PISSN: 00313998     EISSN: 15300447     Source Type: Journal    
DOI: 10.1038/pr.2012.110     Document Type: Article

References (34)

1. Levy O, Martin S, Eichenwald E, et al. Impaired innate immunity in the newborn: newborn neutrophils are deficient in bactericidal/ permeabilityincreasing protein. Pediatrics 1999;104:1327-33.
2. Schelonka RL, Infante AJ. Neonatal immunology. Semin Perinatol 1998;22:2-14. (Pubitemid 28162325)
3. Lin PW, Stoll BJ. Necrotising enterocolitis. Lancet 2006;368:1271-83. (Pubitemid 44485800)
4. Blakely ML, Tyson JE, Lally KP, et al. Laparotomy versus peritoneal drainage for necrotizing enterocolitis or isolated intestinal perforation in extremely low birth weight infants: outcomes through 18 months adjusted age. Pediatrics 2006;117:e680-7. (Pubitemid 46071471)
5. Gewolb IH, Schwalbe RS, Taciak VL, Harrison TS, Panigrahi P. Stool microflora in extremely low birthweight infants. Arch Dis Child Fetal Neonatal Ed 1999;80:F167-73. (Pubitemid 29453033)
6. Huttner KM, Bevins CL. Antimicrobial peptides as mediators of epithelial host defense. Pediatr Res 1999;45:785-94. (Pubitemid 29250083)
7. Zilbauer M, Jenke A, Wenzel G, et al. Expression of human beta-defensins in children with chronic inflammatory bowel disease. PLoS ONE 2010; 5:e15389.
8. Schrer JM, Harder J. Human beta-defensin-2. Int J Biochem Cell Biol 1999;31:645-51. (Pubitemid 29248873)
9. Richter M, Topf HG, Grchl M, et al. Influence of gestational age, cesarean section, and type of feeding on fecal human beta-defensin 2 and tumor necrosis factor-alpha. J Pediatr Gastroenterol Nutr 2010;51:103-5.
10. Gariboldi S, Palazzo M, Zanobbio L, et al. Low molecular weight hyaluronic acid increases the self-defense of skin epithelium by induction of beta-defensin 2 via TLR2 and TLR4. J Immunol 2008;181:2103-10.
11. Visintin A, Mazzoni A, Spitzer JA, Segal DM. Secreted MD-2 is a large polymeric protein that efficiently confers lipopolysaccharide sensitivity to Toll-like receptor 4. Proc Natl Acad Sci USA 2001;98:12156-61. (Pubitemid 32959843)
12. Leaphart CL, Cavallo J, Gribar SC, et al. A critical role for TLR4 in the pathogenesis of necrotizing enterocolitis by modulating intestinal injury and repair. J Immunol 2007;179:4808-20.
13. Wolfs TG, Derikx JP, Hodin CM, et al. Localization of the lipopolysaccharide recognition complex in the human healthy and inflamed premature and adult gut. Inflamm Bowel Dis 2010;16:68-75.
14. Sadeghi K, Berger A, Langgartner M, et al. Immaturity of infection control in preterm and term newborns is associated with impaired toll-like receptor signaling. J Infect Dis 2007;195:296-302. (Pubitemid 46080062)
15. Josefsson S, Bunn SK, Domell M. Fecal calprotectin in very low birth weight infants. J Pediatr Gastroenterol Nutr 2007;44:407-13. (Pubitemid 46573221)
16. Khurana S, George SP. Regulation of cell structure and function by actinbinding proteins: villin's perspective. FEBS Lett 2008;582:2128-39.
17. Kersting S, Bruewer M, Schuermann G, et al. Antigen transport and cytoskeletal characteristics of a distinct enterocyte population in inflammatory bowel diseases. Am J Pathol 2004;165:425-37. (Pubitemid 38971373)
18. Wang Y, Srinivasan K, Siddiqui MR, George SP, Tomar A, Khurana S. A novel role for villin in intestinal epithelial cell survival and homeostasis. J Biol Chem 2008;283:9454-64.
19. Niyonsaba F, Ogawa H, Nagaoka I. Human beta-defensin-2 functions as a chemotactic agent for tumour necrosis factor-alpha-treated human neutrophils. Immunology 2004;111:273-81. (Pubitemid 38365749)
20. Splawski JB, Jelinek DF, Lipsky PE. Delineation of the functional capacity of human neonatal lymphocytes. J Clin Invest 1991;87:545-53.
21. Varoga D, Klostermeier E, Paulsen F, et al. The antimicrobial peptide HBD-2 and the Toll-like receptors-2 and-4 are induced in synovial membranes in case of septic arthritis. Virchows Arch 2009;454:685-94.
22. Sadeghi K, Berger A, Langgartner M, et al. Immaturity of infection control in preterm and term newborns is associated with impaired toll-like receptor signaling. J Infect Dis 2007;195:296-302. (Pubitemid 46080062)
23. Sodhi CP, Shi XH, Richardson WM, et al. Toll-like receptor-4 inhibits enterocyte proliferation via impaired beta-catenin signaling in necrotizing enterocolitis. Gastroenterology 2010;138:185-96.
24. Tatum PM Jr, Harmon CM, Lorenz RG, Dimmitt RA. Toll-like receptor 4 is protective against neonatal murine ischemia-reperfusion intestinal injury. J Pediatr Surg 2010;45:1246-55.
25. Soto E, Espinoza J, Nien JK, et al. Human beta-defensin-2: a natural antimicrobial peptide present in amniotic fluid participates in the host response to microbial invasion of the amniotic cavity. J Matern Fetal Neonatal Med 2007;20:15-22. (Pubitemid 47215725)
26. Iavazzo C, Tassis K, Gourgiotis D, et al. The role of human beta defensins 2 and 3 in the second trimester amniotic fluid in predicting preterm labor and premature rupture of membranes. Arch Gynecol Obstet 2010;281:793-9.
27. Campeotto F, Baldassarre M, Laforgia N, et al. Fecal expression of human ?-defensin-2 following birth. Neonatology 2010;98:365-9.
28. McCray PB Jr, Bentley L. Human airway epithelia express a beta-defensin. Am J Respir Cell Mol Biol 1997;16:343-9. (Pubitemid 127497458)
29. Starner TD, Agerberth B, Gudmundsson GH, McCray PB Jr. Expression and activity of beta-defensins and LL-37 in the developing human lung. J Immunol 2005;174:1608-15.
30. Jia HP, Starner T, Ackermann M, Kirby P, Tack BF, McCray PB Jr. Abundant human beta-defensin-1 expression in milk and mammary gland epithelium. J Pediatr 2001;138:109-12. (Pubitemid 32097151)
31. Naess-Andresen CF, Egelandsdal B, Fagerhol MK. Calcium binding and concomitant changes in the structure and heat stability of calprotectin (L1 protein). Clin Mol Pathol 1995;48:M278-84.
32. Kliegman RM, Walsh MC. Neonatal necrotizing enterocolitis: pathogenesis, classification, and spectrum of illness. Curr Probl Pediatr 1987;17:213-88.
33. Schrer O, Naumann M, Shastri Y, Povse N, Stein J. Prospective evaluation of faecal neutrophil-derived proteins in identifying intestinal inflammation: combination of parameters does not improve diagnostic accuracy of calprotectin. Aliment Pharmacol Ther 2007;26:1035-42. (Pubitemid 47416301)
34. Vandesompele J, De Preter K, Pattyn F, et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 2002;3:RESEARCH0034.